Event JSON
{
"id": "28660e290081aaea7f4497679036260526e7440b445c4a8a38d8672fc0107f94",
"pubkey": "6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"created_at": 1731669081,
"kind": 1,
"tags": [
[
"r",
"https://finance.yahoo.com/news/2-strong-buy-penny-stocks-104100869.html"
],
[
"subject",
"These 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say Analysts"
],
[
"published_at",
"1731667260"
],
[
"image",
"https://media.zenfs.com/en/tipranks_452/7e0310c4fe464d5196b201f3e1243e4f"
],
[
"p",
"6742ae4103f4faeb83264d955f742f9a611ac80190cc0043e3b322318cc7ee61",
"wss://relay-testnet.k8s.layer3.news"
],
[
"imeta",
"url https://media.zenfs.com/en/tipranks_452/7e0310c4fe464d5196b201f3e1243e4f"
],
[
"t",
"neutral:perspective"
],
[
"summary",
"The article highlights the potential of two penny stocks, Genelux Corporation (GNLX) and SAB Biotherapeutics (SABS), which are working on developing new cancer treatments and autoimmune disease therapies, respectively. Both companies have received positive reviews from analysts, with potential for significant growth in the coming year."
]
],
"content": "nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy\nhttps://media.zenfs.com/en/tipranks_452/7e0310c4fe464d5196b201f3e1243e4f\n\nhttps://finance.yahoo.com/news/2-strong-buy-penny-stocks-104100869.html",
"sig": "e3f3b57da617088ac4e815af6bd7bfded8b9df98beb4cc76323d565e6fcf5195c150eb9a3f4c9f6b8d2488c4f947f21c6c97a1f05dc33494711ffde7e51e1e43"
}